Mechanism of glial activation by S100B: Involvement of the transcription factor NFκB

Neurobiology of Aging

Volumn 22, Issue 5, 2001, Pages 765-772

  Lam, Amy G M ^a   Koppal, Tanuja ^a   Akama, Keith T ^a   Guo, Ling ^a   Craft, Jeffrey M ^a   Samy, Barat ^a   Schavocky, James P ^a   Martin Watterson, D ^a   Van Eldik, Linda J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Astrocyte; Cytokine; Glia; iNOS; NF B; Nitric oxide; S100B

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; PROTEIN S 100; PROTEIN S100B; PROTEIN SUBUNIT; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN FUNCTION; BRAIN LEVEL; CELL ACTIVATION; CONTROLLED STUDY; DNA BINDING; DNA RESPONSIVE ELEMENT; ENZYME ACTIVATION; GENETIC TRANSFECTION; GLIA; MUTATION; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; RAT; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; CEREBRAL CORTEX; ENZYME ACTIVATION; NERVE GROWTH FACTORS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; S100 PROTEINS; TRANSCRIPTION, GENETIC;

EID: 0035173607     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00233-0     Document Type: Article

References (53)

1. Gene encoding the beta subunit of S100 protein is on chromosome 21: Implications for Down syndrome
2. β-amyloid stimulation of inducible nitric oxide synthase in astrocytes is IL-1β-, and TNF-α (TNFα)-dependent, and involves a TNFα receptor-associated factor-, and NFκB-inducing kinase-dependent signaling mechanism
3. Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism
4. Inflammation and Alzheimer's disease
5. Neuronal survival activity of S100ββ is enhanced by calcineurin inhibitors and requires NFκB
6. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
7. S100β, and serotonin: A possible astrocytic-neuronal link to neuropathology of Alzheimer's disease
8. NFκB: Ten years after
9. NFκB-like factors in the murine brain. Developmentally-regulated and tissue-specific expression
10. The NFκB/Rel family of proteins mediates Aβ-induced neurotoxicity, and glial activation
11. 2+ accumulation
12. Disulfide-linked S100 beta dimers, and signal transduction
13. TPL-2 kinase regulates the proteolysis of the NFκB inhibitory protein NFκB1-p105
14. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NFκB activation
15. Nuclear translocation of NFκB in cholinergic patients with Alzheimer's disease
16. Oxidative stress and nuclear factor-κB activation. A reassessment of the evidence in the light of recent discoveries
17. IL-1-induced iNOS expression in human astrocytes via NFκB
18. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes
19. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type
20. NFκB immunoreactivity is observed in association with βA4 diffuse plaques in patients with Alzheimer's disease
21. Overexpression of a calcium-binding protein, S100β, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice
22. NFkappaB, and Rel proteins: Evolutionarily conserved mediators of immune responses
23. Extracellular S100B protein modulates ERK in astrocyte cultures
24. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression
25. Overexpression of the neurotrophic cytokine S100β in human temporal lobe epilepsy
26. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
27. Synaptic activation of NFκB by glutamate in cerebellar granule neurons in vitro
28. Changes in Ca(2+)-binding proteins in human neurodegenerative disorders
29. RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides
30. Glial derived proteins activate cultured astrocytes and enhance β-amyloid-induced astrocyte activation
31. S100β induces neuronal cell death through nitric oxide release from astrocytes
32. S100β stimulates inducible nitric oxide synthase activity, and mRNA levels in rat cortical astrocytes
33. Coregulation of neurite outgrowth and cell survival by amphotericin and S100 proteins through RAGE activation
34. Tyrosine phosphorylation of IκBα activates NFκB without proteolytic degradation of IκBα
35. Transcription factor NFκB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer's disease
36. Stimulation of ionotrophic glutamate receptors activates transcription factor NFκB in primary neurons
37. Constitutive NFκB activity in neurons
38. Purification and characterization of a neurite extension factor from bovine brain
39. S100β as a neurotrophic factor
40. Roles of nuclear factor κB in neuronal survival and plasticity
41. Activation of NFκB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of Mn-SOD and suppression of peroxynitrite production and protein tyrosine nitration
42. Rel/NF-κB/IκB story
43. A soluble protein characteristic of the nervous system
44. NF-κB: A crucial transcription factor for glial, and neuronal cell function
45. Modulation of glial activation by astrocyte-derived protein S100B: Differential responses of astrocyte and microglial cultures
46. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease
47. S100β protein expression in Alzheimer disease: Potential role in the pathogenesis of neuritic plaques
48. Structure, regulation, and function of NF-κB
49. S100β expression in Alzheimer's diesease: Relation to neuropathology in brain regions
50. Synthesis and expression of a gene coding for the calcium-modulated protein S100β and designed for cassette-based site-directed mutagenesis
51. Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: Implications for Alzheimer's disesease and Down's syndrome
52. Learning and memory in S100-β transgenic mice: An analysis of impaired and preserved function
53. RAGE, and amyloid-beta peptide neurotoxicity in Alzheimer's disease